X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16603) 16603
Newsletter (4242) 4242
Book Review (1517) 1517
Publication (940) 940
Conference Proceeding (130) 130
Magazine Article (120) 120
Newspaper Article (118) 118
Dissertation (48) 48
Trade Publication Article (32) 32
Book Chapter (28) 28
Paper (7) 7
Web Resource (3) 3
Book / eBook (1) 1
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
simvastatin (16245) 16245
index medicus (11348) 11348
humans (9196) 9196
male (6333) 6333
female (5100) 5100
statins (4749) 4749
middle aged (4102) 4102
antilipemic agents (3552) 3552
research (3519) 3519
cholesterol (3513) 3513
animals (3153) 3153
aged (3083) 3083
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2922) 2922
simvastatin - therapeutic use (2831) 2831
pharmacology & pharmacy (2712) 2712
atorvastatin (2573) 2573
simvastatin - pharmacology (2498) 2498
adult (2463) 2463
cardiac & cardiovascular systems (2138) 2138
hypercholesterolemia (2067) 2067
pravastatin (2058) 2058
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (1965) 1965
anticholesteremic agents - therapeutic use (1806) 1806
drugs (1786) 1786
reports (1773) 1773
risk factors (1683) 1683
abridged index medicus (1681) 1681
treatment outcome (1665) 1665
analysis (1613) 1613
rats (1588) 1588
lovastatin (1543) 1543
hypercholesterolemia - drug therapy (1533) 1533
simvastatin - administration & dosage (1524) 1524
cholesterol, ldl - blood (1512) 1512
atherosclerosis (1466) 1466
care and treatment (1427) 1427
medicine, general & internal (1327) 1327
drug therapy (1316) 1316
lipids (1312) 1312
universities and colleges (1244) 1244
risk (1226) 1226
peripheral vascular disease (1221) 1221
prevention (1221) 1221
medical research (1218) 1218
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1172) 1172
coronary-heart-disease (1144) 1144
atorvastatin calcium (1138) 1138
therapy (1132) 1132
cholesterol - blood (1121) 1121
drug therapy, combination (1077) 1077
low density lipoproteins (1076) 1076
mice (1075) 1075
medicine, experimental (1056) 1056
cardiovascular agents (1023) 1023
ezetimibe (1014) 1014
inflammation (991) 991
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (989) 989
statin (979) 979
dose-response relationship, drug (978) 978
disease (916) 916
lovastatin - analogs & derivatives (882) 882
cardiovascular disease (875) 875
health aspects (865) 865
apoptosis (860) 860
expression (849) 849
simvastatin - adverse effects (845) 845
coa reductase inhibitors (837) 837
time factors (832) 832
double-blind method (831) 831
dosage and administration (829) 829
hypolipidemic agents - therapeutic use (826) 826
coronary heart disease (803) 803
mortality (799) 799
diabetes (784) 784
heptanoic acids - therapeutic use (780) 780
cardiovascular diseases (775) 775
pyrroles - therapeutic use (769) 769
lipids - blood (766) 766
triglycerides - blood (748) 748
efficacy (742) 742
biochemistry & molecular biology (731) 731
myocardial-infarction (725) 725
cells, cultured (712) 712
physiological aspects (712) 712
endocrinology & metabolism (706) 706
lovastatin - therapeutic use (696) 696
anticholesteremic agents - administration & dosage (684) 684
hypercholesterolemia - blood (683) 683
medicine, research & experimental (681) 681
anticholesteremic agents - pharmacology (678) 678
safety (674) 674
aged, 80 and over (673) 673
rosuvastatin (668) 668
clinical trials (667) 667
c-reactive protein (663) 663
in-vitro (658) 658
cholesterol, hdl - blood (639) 639
hyperlipidemias - drug therapy (638) 638
drug interactions (636) 636
cardiovascular (625) 625
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20069) 20069
German (180) 180
Chinese (164) 164
Russian (144) 144
Spanish (131) 131
French (117) 117
Portuguese (68) 68
Italian (65) 65
Korean (43) 43
Japanese (42) 42
Polish (39) 39
Swedish (35) 35
Czech (20) 20
Danish (19) 19
Hungarian (15) 15
Dutch (14) 14
Norwegian (14) 14
Turkish (13) 13
Persian (5) 5
Croatian (3) 3
Finnish (3) 3
Romanian (2) 2
Arabic (1) 1
Catalan (1) 1
Hebrew (1) 1
Malay (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmaceutical Research, ISSN 0724-8741, 6/2015, Volume 32, Issue 6, pp. 1864 - 1883
To develop a population physiologically-based pharmacokinetic (PBPK) model for simvastatin (SV) and its active metabolite, simvastatin acid (SVA), that allows... 
Biochemistry, general | Biomedical Engineering | drug-drug interactions | Biomedicine | Pharmacy | PBPK | simvastatin | Medical Law | population model | Pharmacology/Toxicology | OATP1B1 | HYDROXY ACID | VARIANTS | DRUG-INTERACTIONS | "simvastatin" | QUANTIFICATION | IN-VITRO DATA | "population model" | "OATP1B1" | STATINS | CHEMISTRY, MULTIDISCIPLINARY | DISPOSITION | PRIOR DISTRIBUTIONS | "PBPK" | PHARMACOLOGY & PHARMACY | "drug-drug interactions" | PRAVASTATIN | INHIBITORS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Activation, Metabolic | Cytochrome P-450 Enzyme Inhibitors - therapeutic use | Simvastatin - adverse effects | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Biological Availability | Muscle, Skeletal - metabolism | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Healthy Volunteers | Simvastatin - blood | Organic Anion Transporters - metabolism | Tissue Distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | Drug Interactions | Liver - drug effects | Muscle, Skeletal - drug effects | Muscular Diseases - chemically induced | Pharmacogenetics | Reproducibility of Results | Simvastatin - chemistry | Muscular Diseases - metabolism | Simvastatin - administration & dosage | Liver - metabolism | Simvastatin - pharmacokinetics | Simvastatin - analogs & derivatives | Polymorphism, Genetic | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Models, Biological | Solute Carrier Organic Anion Transporter Family Member 1b1 | Metabolites | Simvastatin | Drug interactions | Liver | Cytochrome P-450 | Antilipemic agents | Side effects | Pharmacology | Kinetics | Statins | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 16, pp. C174 - C175
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 12/2006, Volume 16, Issue 12, pp. 873 - 879
Journal Article
JAMA DERMATOLOGY, ISSN 2168-6068, 06/2018, Volume 154, Issue 6, pp. 725 - 726
Journal Article
Journal Article
Experimental Eye Research, ISSN 0014-4835, 03/2007, Volume 84, Issue 3, p. 464
Proliferative vitreoretinopathy (PVR) is a major cause of the failure of rhegmatogenous retinal detachment surgery. The pathogenesis of PVR includes a fibrotic... 
Simvastatin
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 01/2007, Volume 9, Issue 1, p. 30
Simvastatin can prevent cardiac remodelling after myocardial infarction, though the exact mechanisms are uncertain. Myocardial no-reflow is associated with... 
Simvastatin
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 10/2014, Volume 96, Issue 4, pp. 423 - 428
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 02/2019, Volume 164, pp. 258 - 267
Statins, HMG-CoA reductase inhibitors, are considered the first line treatment of hyperlipidemia to reduce the risk of atherosclerotic cardiovascular diseases.... 
Obese subjects from GBS | Hyperlipidemic plasma | Simvastatin and metabolite | Rosuvastatin | Atorvastatin and metabolites | LC–MS/MS | MS-MS METHOD | LC-MS/MS | CHEMISTRY, ANALYTICAL | ACID | SIMULTANEOUS QUANTITATION | PHARMACOLOGY & PHARMACY | SIMULTANEOUS QUANTIFICATION | Simvastatin - therapeutic use | Gastric Bypass | Chromatography, High Pressure Liquid - methods | Hyperlipidemias - blood | Rosuvastatin Calcium - therapeutic use | Humans | Middle Aged | Male | Simvastatin - pharmacology | Obesity - blood | Simvastatin - blood | Atherosclerosis - etiology | Adult | Female | Atorvastatin - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Rosuvastatin Calcium - blood | Tandem Mass Spectrometry - methods | Hyperlipidemias - complications | Obesity - surgery | Tandem Mass Spectrometry - instrumentation | Reproducibility of Results | Obesity - complications | Hyperlipidemias - drug therapy | Rosuvastatin Calcium - pharmacology | Atorvastatin - therapeutic use | Postoperative Period | Chromatography, High Pressure Liquid - instrumentation | Atorvastatin - pharmacology | Calibration | Simvastatin - analogs & derivatives | Atorvastatin - analogs & derivatives | Atherosclerosis - prevention & control | Preoperative Period | Obesity | Medical research | Simvastatin | Gastric bypass | Organic acids | Cardiovascular agents | Antilipemic agents | Metabolites | Analysis | Formic acid | Medicine, Experimental | Nitriles | Index Medicus
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 3/2015, Volume 71, Issue 3, pp. 341 - 355
Systemic exposure to rosuvastatin is approximately double that of Caucasians in Asian subjects. We investigated whether this pattern of increased exposure... 
SLCO1B1 | Pharmacogenetics | Biomedicine | Caucasian | Pharmacology/Toxicology | Pharmacokinetics | Asian | ABCG2 | WHITE | ADULT MALE-VOLUNTEERS | RISK | OATP1B1 | DISPOSITION | MARKEDLY AFFECTS | TRANSPORT | SYSTEMIC EXPOSURE | DISEASE | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Simvastatin - adverse effects | Atorvastatin Calcium - blood | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Middle Aged | Rosuvastatin Calcium - adverse effects | Asian Continental Ancestry Group - genetics | Male | Simvastatin - blood | Young Adult | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | ATP-Binding Cassette Transporters - genetics | Adult | Female | Neoplasm Proteins - genetics | Rosuvastatin Calcium - blood | Atorvastatin Calcium - adverse effects | Atorvastatin Calcium - pharmacokinetics | European Continental Ancestry Group - genetics | Rosuvastatin Calcium - pharmacokinetics | Genotype | Simvastatin - pharmacokinetics | Simvastatin - analogs & derivatives | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Adolescent | Polymorphism, Single Nucleotide - genetics | Aged | Solute Carrier Organic Anion Transporter Family Member 1b1 | Genetic aspects | Rosuvastatin | Simvastatin | Antilipemic agents | Genotype & phenotype | Whites | Pharmacology | Statins | Asians | Polymorphism | Index Medicus
Journal Article